Investor Relations - DASA

About DASA

Overview

Strategy

Competitive Advantage

Presence in the Market

Medical Diagnostic Market

Overview

Supplementary Health

Corporate Governance

Corporate Governance

Pulverized Capital

Governance Structure

Bylaws

Corporate Responsibility

Corporate Responsibility

About our Brands

Brands Segmentation

Area of Expertise

Earnings Reports

Quarterly Reports

Other information

Notice and Minutes

Market Announcements

Notice to Shareholders

Meeting Minutes

Shareholders

Shareholders Services

Dividends

Dividends Policy

Events and Presentation

Conference Calls

Analysts Coverage

Analysts

Ratings

Ratings Agencies

Press

Contact IR Team

Contact

Downloads

Downloads

Earnings Results 3Q11

Portuguese Call: 11/16 10h00 (Brasília), 7h00 (NY Time) Phone: 55 (11) 2188-0155 Code: Dasa English Cal 11/16 12h00 (Brasília Time), 9h00 (NY Time) Phone: 1(973) 935-8893 Code: 20658343
Invite Presentation	Earnings Release Webcast
Financial Statements

	518 Private Patient Service Centers (3Q11)
	Present in 13 Brazilian estates and in the Federal District
	Operates in diversify segments: Private, Public and Lab-to-Lab
	Offer more than 3.000 tests
	18 Acquisitions since 2005
	Certifications: ISO 9001, ISO 14001, OHSAS 18001 and PALC
	Accreditations: CAP – College of American Pathologists

Investor Kit

	Historical Series 3Q11
	Financial Statements 3Q11
	Quartely Results 3Q11
	Kit Download

	01/03 to 01/06 Morgan Stanley Conference - Miami
	01/09 to 01/10 JPM Health Care Conference - San Francisco
	01/10 to 01/12 16th. Anual Conference Santander Latin America – Cancún
	01/18 V Ideas Conference Credit Suisse – São Paulo